First Occurrence of Fatal Intoxication Involving Methiodone (IC-26) in Finland; a Medicolegal Autopsy Case Report.

Drug Test AnalSep 11, 2026 (epub)
Case ReportPathology (Anatomic & Clinical)Open access

Lasse Pakanen, Raimo A Ketola, Pirkko Kriikku

✦ AI-curated · Sources linked

Case in brief

A person receiving opioid agonist treatment died from an intoxication in which methiodone (IC-26), a non-fentanyl synthetic opioid, was identified as the primary intoxicant. Medicolegal autopsy toxicology detected methiodone at 1.5 mg/L in femoral vein blood. The report describes this as the first published fatal intoxication involving methiodone in Finland.

What made this case unusual

Methiodone, a novel synthetic opioid with limited published toxicological case data, was identified as the primary intoxicant in a fatal case involving a person undergoing opioid agonist treatment.

Diagnostic / clinical pearl

In suspected opioid intoxication, toxicological assessment may need to consider novel synthetic opioids such as methiodone, including in people receiving opioid agonist treatment.

Why it matters

The case highlights the value of monitoring for substance use during substitution therapy, including possible exposure to emerging synthetic opioids.

Source

Published in Drug Test Anal. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pathology (Anatomic & Clinical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.